SYNTH MR Share Price Swiss Exchange
Equities
SE0005454865
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- SEK | - |
|
09/07 | SyntheticMR AB Provides Sales Guidance for the Second Quarter of 2024 | CI |
22/05 | SyntheticMR AB Announces Board Changes | CI |
Sales 2024 * | 7.62Cr 72.32L 60Cr | Sales 2025 * | 9.92Cr 94.12L 79Cr | Capitalization | 115.48Cr 11Cr 915.52Cr |
---|---|---|---|---|---|
Net income 2024 * | 40L 4L 3.17Cr | Net income 2025 * | 1.4Cr 13.28L 11Cr | EV / Sales 2024 * | 15.1 x |
Net cash position 2024 * | 68.2L 6L 5.41Cr | Net cash position 2025 * | 68.14L 6L 5.4Cr | EV / Sales 2025 * | 11.6 x |
P/E ratio 2024 * |
277
x | P/E ratio 2025 * |
82.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
0.54% | Free-Float | 42.6% |
Managers | Title | Age | Since |
---|---|---|---|
Ulrik Harrysson
CEO | Chief Executive Officer | 55 | 01/19/01 |
Founder | 51 | 16/07/16 | |
Johanna Norén
DFI | Director of Finance/CFO | 50 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 01/13/01 | |
Director/Board Member | 60 | 01/21/01 | |
Founder | 51 | 16/07/16 |
1st Jan change | Capi. | |
---|---|---|
-5.50% | 3.03TCr | |
+40.35% | 946.53Cr | |
+31.81% | 432.89Cr | |
-36.88% | 249.08Cr | |
-6.48% | 166.3Cr | |
-23.84% | 126.57Cr | |
-42.92% | 97Cr | |
-3.96% | 89Cr | |
-50.69% | 69Cr |